SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-163872
Filing Date
2017-05-09
Accepted
2017-05-09 13:26:55
Documents
56
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d380147d10q.htm 10-Q 573828
2 EX-10.1 d380147dex101.htm EX-10.1 26119
3 EX-10.2 d380147dex102.htm EX-10.2 11673
4 EX-10.3 d380147dex103.htm EX-10.3 28028
5 EX-10.4 d380147dex104.htm EX-10.4 18302
6 EX-31.1 d380147dex311.htm EX-31.1 6918
7 EX-31.2 d380147dex312.htm EX-31.2 6866
8 EX-32.1 d380147dex321.htm EX-32.1 4389
  Complete submission text file 0001193125-17-163872.txt   2875442

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT sndx-20170331.xml EX-101.INS 389265
10 XBRL TAXONOMY EXTENSION SCHEMA sndx-20170331.xsd EX-101.SCH 38556
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20170331_cal.xml EX-101.CAL 48945
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20170331_def.xml EX-101.DEF 116091
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20170331_lab.xml EX-101.LAB 303307
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20170331_pre.xml EX-101.PRE 204033
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 17825626
SIC: 2834 Pharmaceutical Preparations